Pitcairn CO Takeda Pharmaceutical CO LTD Transaction History
Pitcairn CO
- $1.67 Billion
- Q4 2024
A detailed history of Pitcairn CO transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Pitcairn CO holds 17,463 shares of TAK stock, worth $265,088. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,463
Previous 12,436
40.42%
Holding current value
$265,088
Previous $176,000
31.25%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding TAK
# of Institutions
339Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$200 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$85 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$70.3 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$64 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$49.2 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $47.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...